To reduce Bundibugyo Virus Disease and prevent avoidable illness and death in the Democratic Republic of the Congo, Uganda, and at-risk countries through end-to-end procurement of critical therapeutics, diagnostics, and medical supplies

Grant number: INV-108745

Grant search

Key facts

  • Disease

    Ebola
  • Start & end year

    2026
    2027
  • Known Financial Commitments (USD)

    $5,000,000
  • Funder

    Gates Foundation
  • Research Location

    180; 800
  • Lead Research Institution

    World Health Organization
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics
  • Research Subcategory

    Diagnostics
  • Special Interest Tags

    N/A
  • Study Type

    Not applicable
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Unspecified
  • Vulnerable Population

    Unspecified
  • Occupations of Interest

    Unspecified

Abstract

To reduce Bundibugyo Virus Disease and prevent avoidable illness and death in the Democratic Republic of the Congo, Uganda, and at-risk countries through end-to-end procurement of critical therapeutics, diagnostics, and medical supplies